Literature DB >> 28170077

Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.

L S Santana1, L A Caetano1,2, A D Costa-Riquetto1,2, E P S Quedas1, M Nery2, P Collett-Solberg3, M C S Boguszewski4, M F Vendramini5, L G Crisostomo6,7, F O Floh6, Z I Zarabia8, S K Kohara9, L Guastapaglia10, C G B Passone11, L E Sewaybricker12, A A L Jorge1, M G Teles1,2.   

Abstract

Maturity-onset diabetes of the young (MODY) is a form of monogenic diabetes with autosomal dominant inheritance. GCK -MODY and HNF1A -MODY are the prevalent subtypes. Currently, there is growing concern regarding the correct interpretation of molecular genetic findings. The American College of Medical Genetics and Genomics (ACMG) updated guidelines to interpret and classify molecular variants. This study aimed to determine the prevalence of MODY ( GCK / HNF1A ) in a large cohort of Brazilian families, to report variants related to phenotype, and to classify them according to ACMG guidelines. One hundred and nine probands were investigated, 45% with clinical suspicion of GCK -MODY and 55% with suspicion of HNF1A -MODY. Twenty-five different variants were identified in GCK gene (30 probands-61% of positivity), and 7 variants in HNF1A (10 probands-17% of positivity). Fourteen of them were novel (12- GCK /2- HNF1A ). ACMG guidelines were able to classify a large portion of variants as pathogenic (36%- GCK /86%- HNF1A ) and likely pathogenic (44%- GCK /14%- HNF1A ), with 16% (5/32) as uncertain significance. This allows us to determine the pathogenicity classification more efficiently, and also reinforces the suspected associations with the phenotype among novel variants.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ACMG; GCK; HNF1A; MODY

Mesh:

Substances:

Year:  2017        PMID: 28170077     DOI: 10.1111/cge.12988

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  Identification of Variants Responsible for Monogenic Forms of Diabetes in Brazil.

Authors:  Gabriella de Medeiros Abreu; Roberta Magalhães Tarantino; Ana Carolina Proença da Fonseca; Juliana Rosa Ferreira de Oliveira Andrade; Ritiele Bastos de Souza; Camila de Almeida Pereira Dias Soares; Amanda Cambraia; Pedro Hernan Cabello; Melanie Rodacki; Lenita Zajdenverg; Verônica Marques Zembrzuski; Mário Campos Junior
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

2.  Targeted sequencing identifies novel variants in common and rare MODY genes.

Authors:  Lucas S de Santana; Lilian A Caetano; Aline D Costa-Riquetto; Pedro C Franco; Renata P Dotto; André F Reis; Letícia S Weinert; Sandra P Silveiro; Marcio F Vendramini; Flaviene A do Prado; Giovanna C P Abrahão; Ana Gregória F P de Almeida; Maria da G Rodrigues Tavares; Wagner Rodrigo B Gonçalves; Augusto C Santomauro Junior; Bruno Halpern; Alexander A L Jorge; Marcia Nery; Milena G Teles
Journal:  Mol Genet Genomic Med       Date:  2019-10-08       Impact factor: 2.183

3.  Identification and functional analysis of GCK gene mutations in 12 Chinese families with hyperglycemia.

Authors:  Zhixin Wang; Chengming Diao; Yijing Liu; Mingmin Li; Jia Zheng; Qian Zhang; Miao Yu; Huabing Zhang; Fan Ping; Ming Li; Xinhua Xiao
Journal:  J Diabetes Investig       Date:  2019-02-01       Impact factor: 4.232

4.  Screening for extremely rare pathogenic variants of monogenic diabetes using targeted panel sequencing.

Authors:  Tomasz Płoszaj; Karolina Antosik; Paulina Jakiel; Agnieszka Zmysłowska; Maciej Borowiec
Journal:  Endocrine       Date:  2021-05-21       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.